SEC Form 4 · accession 0001645627-17-000022
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 23, 2017
Accepted (ET)
Mar 27, 2017 · 2:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.052 | A | 19,864,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0527 | A | 19,865,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.053 | A | 19,866,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0514 | A | 19,867,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.052 | A | 19,868,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.052 | A | 19,869,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.053 | A | 19,870,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0525 | A | 19,871,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.057 | A | 19,872,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.057 | A | 19,873,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.057 | A | 19,874,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0565 | A | 19,875,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.056 | A | 19,876,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.056 | A | 19,877,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0558 | A | 19,878,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0557 | A | 19,879,649 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.055 | A | 19,880,649 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0575 | A | 19,881,649 | D | |
| Common Stock | Mar 24, 2017 | P | 2,000 | $0.053 | A | 19,883,649 | D | |
| Common Stock | Mar 24, 2017 | P | 200 | $0.053 | A | 19,883,849 | D | |
| Common Stock | Mar 24, 2017 | P | 2,000 | $0.0525 | A | 19,885,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0525 | A | 19,886,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.052 | A | 19,887,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0525 | A | 19,888,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.054 | A | 19,889,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0509 | A | 19,890,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0509 | A | 19,891,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.0509 | A | 19,892,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.051 | A | 19,893,849 | D | |
| Common Stock | Mar 24, 2017 | P | 1,000 | $0.051 | A | 19,894,849 | D |
Table II — derivative securities
No Table II lines on this filing.